mood and anxiety disorders | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

402,489 results for “mood and anxiety disorders”

Trials

View all 354896 →

Cognitive Training for Mood and Anxiety Disorders

28 participants · First posted Oct 3, 2014

Not yet recruiting

Whole-Body Hyperthermia for Mood and Anxiety Disorders

240 participants · First posted Nov 22, 2023

Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders

105 participants · First posted Sep 20, 2013

Drugs

View all 4565 →

agonist (CNS diseases/epilepsy/mood disorders)

5-HT2A receptor agonists (mental health disorders/mood disorders)

monoacylglycerol lipase inhibitor (mood disorders, appetite, pain, inflammation)

Organizations

View all 2265 →

MOOD AND ANXIETY RESEARCH, INC.

United States

Alzheimer's Disease And Related Disorders Association, Inc.

United States

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

United States

News

View all 40763 →

New Review Calls for Prioritizing Maternal Mental Health and SSRI Treatment During Pregnancy

GLP-1 Diabetes Drugs Show Promising Potential for Mental Health Treatment

AbbVie Secures $2 Billion Option Deal for Gilgamesh's Next-Generation Psychedelic Therapies

Page 1 of 40249